Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -193,569 | -143,948 | -180,360 | -117,194 | -43,242 |
| Depreciation Amortization | 5,140 | 8,233 | 11,234 | 7,788 | 2,453 |
| Accounts receivable | N/A | N/A | 6,000 | -6,000 | 0 |
| Accounts payable and accrued liabilities | 5,209 | 1,614 | 85 | 1,589 | 1,234 |
| Other Working Capital | -18,401 | 20,121 | -19,022 | 9,113 | 36,408 |
| Other Operating Activity | 29,037 | 32,615 | 22,256 | 20,339 | 3,067 |
| Operating Cash Flow | $-172,584 | $-81,365 | $-159,807 | $-84,365 | $-80 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,273 | -8,401 | -12,244 | -5,661 | -4,553 |
| Purchase Of Investment | -707,953 | -246,334 | -239,366 | -348,497 | -275,224 |
| Sale Of Investment | 459,513 | 323,036 | 278,808 | 245,907 | 25,373 |
| Investing Cash Flow | $-257,713 | $68,301 | $27,198 | $-108,251 | $-254,404 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 296,950 | 3,217 | 22,433 | 153,883 | 219,117 |
| Common Stock Repurchased | -15 | N/A | N/A | -1 | -7 |
| Other Financing Activity | 188,732 | 0 | 94,759 | 0 | 119,914 |
| Financing Cash Flow | $485,667 | $3,217 | $117,192 | $153,882 | $339,024 |
| Beginning Cash Position | 55,528 | 65,375 | 80,792 | 119,526 | 34,986 |
| End Cash Position | 110,898 | 55,528 | 65,375 | 80,792 | 119,526 |
| Net Cash Flow | $55,370 | $-9,847 | $-15,417 | $-38,734 | $84,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,584 | -81,365 | -159,807 | -84,365 | -80 |
| Capital Expenditure | -9,273 | -8,401 | -12,244 | -5,661 | -4,553 |
| Free Cash Flow | -181,857 | -89,766 | -172,051 | -90,026 | -4,633 |